SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-18-000084
Filing Date
2018-09-27
Accepted
2018-09-27 17:11:49
Documents
4
Period of Report
2018-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opiant_8-kx9x27x2018closin.htm 8-K 35767
2 EXHIBIT 1.1 cfco_opntxunderwritingxagr.htm EX-1.1 267692
3 EXHIBIT 5.1 opiant-exhibit51opinioncmp.htm EX-5.1 7783
4 EXHIBIT 99.1 opiantpr_pricingofpublicof.htm EX-99.1 10488
  Complete submission text file 0001385508-18-000084.txt   323111
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 181091725
SIC: 1000 Metal Mining